CHC releases cost-benefit of fish oil
February 28, 2012
THE Complementary Healthcare
Council of Australia has launched a
new report it commissioned from
Deloitte Access Economics, on the
cost-benefits of providing fish oil
supplements to Australians who
have suffered a heart attack.
The report estimates that fish oils
supplementation for Australians
who had survived a recent heart
attack was extremely valuable, with
an estimated cost per ‘Disability
Adjusted Life Years’ (DALY) averted
of $2200.
“When the DALY value was
monetised according to the
estimate from the Australian
Governement Department of
Finance and Deregulation for the
value of a statistical life year, the
analysis found that fish oils
supplements would achieve large
net benefit of around $1.0 billion,”
a CHC statement today said.
The CHC said that despite these
“highly favourable findings” fish oil
supplements are not currently PBS
subsidised and are subject to GST.
“As the evidence of improved
health outcomes and positive net
benefits of complementary
medicine interventions build, it
would be strategic for governments
to review these arrangements,” the
CHC concluded.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Feb 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Feb 12
